Health Care & Life Sciences » Biotechnology | Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
-
3,593.00
4,637.00
54,925.00
81,183.00
30,635
Total Accounts Receivable
-
15,130.00
7,832.00
307.00
2,141.00
5,220
Inventories
-
17,625.00
20,322.00
461.00
1,028.00
1,785
Other Current Assets
-
5,203.00
2,343.00
15,721.00
10,732.00
11,049
Total Current Assets
-
41,551.00
35,134.00
71,414.00
95,084.00
48,689
Net Property, Plant & Equipment
-
3,202.00
4,179.00
5,910.00
5,843.00
5,202
Total Investments and Advances
-
-
-
-
10,000.00
7,448
Intangible Assets
-
75,218.00
88,454.00
6,910.00
6,080.00
5,250
Other Assets
-
-
-
7,624.00
-
905
Total Assets
-
122,209.00
127,767.00
91,858.00
117,007.00
67,494
ST Debt & Current Portion LT Debt
-
-
-
-
3,333.00
Accounts Payable
-
11,472.00
10,084.00
10,518.00
7,350.00
Other Current Liabilities
-
8,363.00
9,859.00
9,026.00
7,827.00
Total Current Liabilities
-
19,835.00
19,943.00
19,544.00
18,510.00
Long-Term Debt
-
-
-
18,383.00
15,728.00
Deferred Taxes
-
1,867.00
15,817.00
-
-
Other Liabilities
-
3,661.00
3,389.00
3,365.00
734.00
Total Liabilities
-
27,601.00
39,149.00
41,292.00
34,972.00
Common Equity (Total)
-
94,608.00
88,618.00
50,566.00
82,035.00
Total Shareholders' Equity
-
94,608.00
88,618.00
50,566.00
82,035.00
Total Equity
-
94,608.00
88,618.00
50,566.00
82,035.00
Liabilities & Shareholders' Equity
-
122,209.00
127,767.00
91,858.00
117,007.00

About Aptevo Therapeutics

View Profile
Address
2401 4th Avenue
Seattle Washington 98121
United States
Employees -
Website http://aptevotherapeutics.com
Updated 07/08/2019
Aptevo Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, commercialization and sale of novel oncology and hematology therapeutics. Its pipeline includes Otlertuzumab, APVO414, APVO436, ROR1 Candidate, and ALG. APV-527.